Results 41 to 50 of about 94,230 (262)
BRONCHOPULMONARY DYSPLASIA IN INFANTS
The paper gives information on a frequent chronic lung disease, such as bronchopulmonary dysplasia, a life-threatening complication of neonatal respiratory distress syndrome, in developed countries.
Ovsyannikov D.Yu. +3 more
openaire +2 more sources
ABSTRACT Microdeletions impacting 15q11.2 breakpoint (BP) 1 to BP2, adjacent to the Prader–Willi critical region, have previously described neuropsychiatric associations, with potential low penetrance presentations of congenital heart disease (CHD) also identified.
Morgan B. Wright +10 more
wiley +1 more source
Bronchopulmonary dysplasia is a major issue affecting morbidity and mortality of surviving premature babies. Preterm newborns are particularly susceptible to oxidative stress and infants with bronchopulmonary dysplasia have a typical oxidation pattern in
Letizia Capasso +7 more
doaj +1 more source
Objectives: To review the literature related to bronchopulmonary dysplasia in extremely pre-mature infants, summarize research direction, and report trends.Methods: CiteSpace is a Java application which supports visual exploration with knowledge ...
Qin Zhou +3 more
doaj +1 more source
Bronchopulmonary Dysplasia: Executive Summary of a Workshop.
Comment in Bronchopulmonary Dysplasia: The Ongoing Search for One Definition to Rule Them All. [J Pediatr. 2018] Midlife crisis? In its 50th year, BPD redefines itself.
Kallapur, Suhas G. +51 more
core +1 more source
Pentoxifylline dose finding trial in preterm neonates with suspected late onset sepsis (PTX‐trial)
Aim The aim of this study (PTX‐trial) is to determine the optimal dose of pentoxifylline (PTX) in preterm neonates (gestational age < 30 weeks) with (suspected) late onset sepsis (LONS). Methods The PTX‐trial is a prospective multicentre open‐label sequential dose‐optimization study with an adapted continual reassessment method.
Serife Kurul +7 more
wiley +1 more source
International audienceRATIONALE: Bronchopulmonary dysplasia is the most common chronic respiratory disease in premature infants. Genetic factors might contribute to bronchopulmonary dysplasia susceptibility.
Juliana Patkai +30 more
core +1 more source
Anakinra, an interleukin‐1 receptor antagonist, shows promise for reducing inflammatory complications of premature birth. However, the pharmacokinetics (PK) of anakinra in neonates has not been characterized, limiting evidence‐based dosing. This study aimed to develop a population PK model for anakinra to guide dosing in preterm neonates.
Jia Li +27 more
wiley +1 more source
Lung organoids: a new frontier in neonatology and paediatric respiratory medicine
Great strides have been made in pre-clinical research in recent decades using animal models and cell lines. However, traditional models may fail to translate to humans, resulting in substantial failure rates in drug development.
Lorenzo Zanetto +6 more
doaj +1 more source
The features of the functional state of the gastrointestinal tract in children with bronchopulmonary dysplasia have been analyzed. It has been shown that children with bronchopulmonary dysplasia have significantly lower indicators of physical development
H.S. Senatorova +3 more
doaj +1 more source

